Pharmacology studies the properties and actions that medication produces in organisms, making it a biological science. Any chemical substance that interacts in the living organism is called a pharmaceutical drug”

master psicofarmacología para psicólogos

In the psychological field, Pharmacology offers a unique opportunity to approach the medicated patient in a precise and concrete manner. Pharmacology offers the possibility of knowing pharmacological drug actions and properties in such a way that they can be prescribed and applied to patients with rigor, with maximum safety, and in optimal conditions. The levels of knowledge may vary depending on the skills and requirements of each person and each profession related to pharmacological therapeutics.

Undoubtedly, the primary objective of Pharmacology is to benefit the patient, and to do so as rationally and strictly as it is usually done to reach the correct diagnosis. Psychologists can help with their expertise in the diagnosis and prescription of the most appropriate medication for each patient. In the last forty years, the development of chemistry, physiology and biochemistry, and analytical technology has made it possible to isolate highly active products from natural sources and, above all, design and synthesize new compounds, analyze their actions and effects at all possible levels of organization of the living substance, and learn about the processes that follow their passage through the organism. This has led to an explosion in the production of therapeutically active pharmaceutical products, an accumulation of information that is not always easy to assimilate, and above all, the possibility of rigorous, objective and individualized application to the characteristics of each patient.

Delay, in 1959, defined psychotropic pharmaceuticals as "chemical substances of natural or synthetic origin, which possess a psychological tropism, i.e., they are capable of modifying mental activity without prejudging the type of modification". Anglo-Saxon authors define psychotropic pharmaceuticals as "chemical substances that modify sensations, mood, consciousness and other psychological and behavioral functions".

This Professional Master’s Degree covers all the current pharmacological knowledge along with the whole universe of expertise that psychologists need to be able to develop their role as psychotherapists in interaction and total coordination with doctors in order to, from there, improve the patient's treatment.

Update your knowledge through this Professional Master’s Degree in Psychopharmacology "

This Professional Master’s Degree in Psychopharmacology contains the most complete and up-to-date educational program on the market. The most important features include:

  • Development of more than 75 clinical cases presented by expert psychologists
  • The graphic, schematic, and practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
  • Diagnostic-therapeutic developments on assessment, diagnosis, and intervention in Psychopharmacology
  • It contains practical exercises where the self assessment process can be carried out to improve learning
  • An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
  • With special emphasis on evidence-based psychology and research methodologies in psychology
  • All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
  • Content that is accessible from any fixed or portable device with an Internet connection

This Professional Master’s Degree may be the best investment you can make when selecting a refresher program, for two reasons: in addition to updating your knowledge in Psychopharmacology , you will obtain a Professional Master’s Degree from TECH Technological University"

The faculty includes professionals from the field of psychology, who bring their experience to this Professional Master’s Degree program, as well as renowned specialists from leading scientific societies.

The multimedia content developed with the latest educational technology will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive program to learn in real situations.

This program is designed around Problem-Based Learning, where students must try to solve the different professional practice situations that arise during the course. For this purpose, psychologists will be supported by an innovative interactive video system created by renowned and experienced experts in the field of Psychopharmacology with extensive teaching experience.

Increase your decision-making confidence by updating your knowledge through this Professional Master’s Degree"

maestria psicofarmacologia para psicplogos

Make the most of this opportunity to learn about the latest advances in Psychopharmacology and improve your patient care"


The structure of the contents has been designed by a team of professionals from the best hospitals and universities, who are aware of the relevance of current specialization in order to intervene with patients with mental health illnesses or psychological alterations and who are committed to quality teaching through new educational technologies.

maestria online psicofarmacología para psicólogos

This Professional Master’s Degree in Psychopharmacology contains the most complete and up to date scientific program on the market”

Module 1. Pharmacology and its Objectives in the Psychological Therapeutic Process

1.1. Anthropological, Historical, Sociological and Psychological Perspective on the Use of Medication
1.2. Pharmacology Objectives
1.3. Concept of Pharmacology
1.4. Therapeutic Pharmacology
1.5. Pharmacodynamics
1.6. Pharmacokinetics
1.7. Plasma Level Curve
1.8. Toxicology
1.9. Social Aspects of Medication
1.10. Medication Intervention Process
1.11. Information Form for the Patient to Receive Psychopharmacological Treatment
1.12. Process for Medication to Become Legal
1.13. Symptoms and Signs, Diseases and Syndromes

Module 2. Anamnesis and the Choice of the Appropriate Medication

2.1. The Interview in a Clinical and Expertise Setting
2.2. Information Theory
2.3. Communication Channels
2.4. Communication System
2.5. Axioms of the Interview
2.6. It is Impossible Not to Communicate
2.7. Content and Relationship
2.8. Affective Value
2.9. Digital and Analog Communication
2.10. Symmetry and Asymmetry
2.11. Exploring Communication
2.12. Verbal Communication
2.13. Non-Verbal Communication
2.14. Double Bond
2.15. Psychopathology of Communication
2.16. A Gesture is Worth a Thousand Words
2.17. Medical History
2.18. General Structure of the Mental Examination
2.19. Semiology
2.20. Epistemology of Diagnosis
2.21. Some Special Types of Clinical Interviews

Module 3. Classification of Psychotropic Medication

3.1. Neurophysiological Foundations of Mental Illness and its Treatment
3.2. Antipsychotics and Neuroleptics
3.3. Anxiolytics and Sedatives
3.4. Antidepressants
3.5. Antimanic or Euthymic Medication
3.6. Antiseizure Medications
3.7. Medication for Agitation
3.8. Pharmacotherapy for Confusion
3.9. Drugs for Dementia
3.10. Medication Against Deficiencies

Module 4. Pharmacological Intervention in Anxiety and Stress Disorders

4.1. Anxiety or Panic Disorder
4.2. Agoraphobia
4.3. Social Phobia
4.4. Specific Phobias
4.5. Generalized Anxiety Disorder
4.6. Obsessive Compulsive Disorder and Related Disorders
4.7. Separation Anxiety Disorder
4.8. Adaptive Disorder
4.9. Dissociative Disorders
4.10. Somatic Symptom Disorders and Associated Conditions
4.11. Trauma and Stress-Related Disorders
4.12. Post-Traumatic Stress
4.13. Disinhibited Social Relationship Disorder

Module 5. Intervention with Psychopharmaceuticals in Depression, Eating Disorders and Sleep Disorders

5.1. Disruptive Mood Dysregulation Disorder
5.2. Major Depressive Disorder
5.3. Persistent Depressive Disorder (Dysthymia)
5.4. Premenstrual Dysphoric Disorder
5.5. Substance-Induced Depressive Disorder
5.6. Pica
5.7. Rumination Disorder
5.8. Food Avoidance Disorder
5.9. Anorexia Nervosa
5.10. Bulimia Nervosa
5.11. Binge Eating Disorder
5.12. Insomnia
5.13. Hypersomnia
5.14. Narcolepsy
5.15. Obstructive Sleep Apnea
5.16. Sleep-Related Hypoventilation
5.17. Non-REM Sleep Awakening Disorders
5.18. Nightmare Disorder
5.19. Restless Leg Syndrome

Module 6. Pharmacotherapy of Psychosis and Dementias

6.1. Schizophrenia and Schizophreniform Psychoses
6.2. Delusional Disorder
6.3. Brief Psychotic Disorder
6.4. Substance-Induced Psychotic Disorder
6.5. Catatonia
6.6. Bipolar Disorder
6.7. Cyclothymic Disorder
6.8. Delirium
6.9. Alzheimer’s Disease
6.10. Frontotemporal Lobe Degeneration
6.11. Dementia due to Brain Trauma
6.12. Vascular Dementia
6.13. Dementia Due to Parkinson’s Disease’
6.14. Dementia Due to Huntington’s Disease
6.15. Personality Disorders
6.16. Latrogenia

Module 7. Medication Used in the Pain Unit

7.1. Medical History the Patient in Pain
7.2. Psychosocial Approach Chronic Pain
7.3. Patient-Controlled Analgesia (PCA)
7.4. Pain in Polytrauma Patients
7.5. Pain in Severe Burns
7.6. Headaches and Facial Pain
7.7. Treatment of Neuralgia
7.8. Treatment of Oncological Pain
7.9. Pain and Terminal Sedation
7.10. Fibromyalgia

unique, key and decisive training experience to boost your professional development”